AI: To Buy or Not to Buy

Shortly after General Electric spun off its HealthCare division, the newly released company started buying AI technology. To share some strategic insights, Digital Science’s IFI CLAIMS Patent Services has taken a look at the target companies’ patents to see what capabilities they’re bringing into the medical technology company.

The phrase ‘patently obvious’ is used in many contexts, from political exchanges to newspaper op-ed columns. Curiously, it is rarely used in the realm of actual patents, but in the case of General Electric’s (GE) HealthCare division, its use seems entirely appropriate.

In early 2023, GE made the decision to spin off GE HealthCare, and immediately following the move the new entity started its M&A strategy by acquiring two companies of its own – Caption Health and IMACTIS. At this early stage, is it possible to infer whether these were sound investments? Six months later, there is still a way to go before full year financial results are posted along with other financial data. However, Digital Science company IFI CLAIMS Patent Services – a global patent database provider for application developers, data scientists, and product managers – can gain insights by looking into the patents the newly enlarged GE HealthCare now holds.

Patents = Strategic Insights

It should be ‘patently obvious’, but checking companies’ patents can be a part of any due diligence process before an investment decision is made. Not only does this help understand risk and technology overlaps, it can also be used to determine where R&D efforts are currently focused in the target acquisition, and in turn set the strategy for the newly merged entity. Analyzing a company’s patent holdings in the midst of M&A dealings provides insights, such as: 

  • Strategic direction of companies (i.e., such as the extent to which they are making strides in AI)
  • Unique takes on M&A transactions as it is possible to determine – based on companies’ technologies – if core competencies overlap or not with the acquiring company
  • Ascertaining if a company’s core competencies are enhanced or not by the acquisitions it’s made

IFI’s latest acquisition report takes a look at GE HealthCare’s acquisitions of IMACTIS and Caption Health’s patented technologies to determine the innovative direction of the company.

‘A good fit’

So what insights can be gleaned from patent data about GE HealthCare and its nascent M&A strategy? According to the report, the acquisition of Caption Health and IMACTIS were a ‘good fit’ for GE HealthCare. Both the acquisitions point towards GE HealthCare’s continued growth in terms of both AI and the application of AI to its existing core technologies. Specifically:

  • IMACTIS is a tech healthcare company that offers, among other things, the provision of 3D virtual imaging to surgical navigation
  • Caption Health focuses on providing AI capabilities and image data generation to ultrasound technologies

You can see from the chart below that GE HealthCare competes with a number of major companies in establishing AI-related patents, which surged in 2019-2020 before dipping in 2021. As such, the acquisitions in the early part of 2023 of companies that are focused on technology and AI in particular seem to be a good strategic move, especially given the furore around AI technology since late 2022.

Competitive landscape for AI patent applications. Source: https://www.ificlaims.com/news/view/blog-posts/the-ifi-deal-ge-healthcare.htm

What the data says

The report concludes that both Caption Health and IMACTIS make sense for GE HealthCare for several reasons. In the current competitive climate, Caption Health adds necessary AI capabilities while IMACTIS adds new dimensions to the suite of patents it has with 3D virtual images. So overall, it’s a gold star for GE HealthCare when it comes to enhancing its patent – and future commercial – strategy. Isn’t that obvious?

Top patented concepts by Caption Health. Source: https://www.ificlaims.com/news/view/blog-posts/the-ifi-deal-ge-healthcare.htm
Top patented concepts by IMACTIS. Source: https://www.ificlaims.com/news/view/blog-posts/the-ifi-deal-ge-healthcare.htm

Three key takeaways

1. Digital Science’s IFI CLAIMS Patent Services – a global patent database provider for application developers, data scientists, and product managers – can help customers gain insights by looking into the patents held by firms, such as newly enlarged GE HealthCare.

2. IFI’s latest acquisition report takes a look at GE HealthCare’s acquisitions of IMACTIS and Caption Health’s patented technologies to determine the innovative direction of the company – the report concludes that both Caption Health and IMACTIS make sense for GE HealthCare for a number of reasons.

3. Checking companies’ patents should be a part of any due diligence process before any corporate investment decision is made, especially in pharmaceuticals sector.

Contact the IFI CLAIMS team
Simon Linacre

About the Author

Simon Linacre, Head of Content, Brand & Press | Digital Science

Simon has 20 years’ experience in scholarly communications. He has lectured and published on the topics of bibliometrics, publication ethics and research impact, and has recently authored a book on predatory publishing. Simon is an ALPSP tutor and has also served as a COPE Trustee.

The post AI: To Buy or Not to Buy appeared first on Digital Science.



from Digital Science https://ift.tt/HtGnMQ2

Comments

Post a Comment

Popular

Words Matter When Discussing Alcohol Issues: A New Stigma-Free Vocabulary for Better AUD Outcomes

Image
Word choice may seem out of place among the myriad factors that can influence outcomes for a complex condition like alcohol use disorder (AUD). In fact, the stigma created by the language that is used to describe alcohol problems can decrease many people’s willingness to seek help for alcohol problems. It also can affect how people with AUD are treated in all aspects of life. “Stigmas are the negative attitudes toward people that are based on certain distinguishing characteristics,” says National Institute on Alcohol Abuse and Alcoholism (NIAAA) Director George F. Koob, Ph.D. “More than a decade of research has shown that stigma contributes significantly to negative health outcomes and can pose a barrier to seeking treatment for mental illness or substance use disorders.” In the United States, nearly 90 percent of people with substance use disorders and 35 percent of people with serious mental illness do not receive treatment. In a recent article published in  Neuropsychopharma...
Read more

‘Massive-scale mobilization’ necessary for addressing climate change, scientists say

Image
A year after a global coalition of more than 11,000 scientists declared a climate emergency, Oregon State University researchers who initiated the declaration released an update today that points to a handful of hopeful signs, but shares continued alarm regarding an overall lack of progress in addressing climate risks. “Young people in more than 3,500 locations around the world have organized to push for urgent action,” said Oregon State University’s William Ripple, who co-authored “The Climate Emergency: 2020 in Review,” published today in Scientific American. “And the Black Lives Matter movement has elevated social injustice and equality to the top of our consciousness. “Rapid progress in each of the climate action steps we outline is possible if framed from the outset in the context of climate justice – climate change is a deeply moral issue. We desperately need those who face the most severe climate risks to help shape the response.” One year ago, Ripple, distinguished profess...
Read more

Researchers advance science behind gut health and prebiotics

Image
When it comes to improving human gut health, approaches and the success of these approaches are based largely on an individual’s gut ecosystem: the bacteria present, its diversity and other factors. Therefore, trying to improve gut health through application of prebiotics or probiotics can have wildly variable results based on gut flora composition. Bruce Hamaker , director of the Whistler Center for Carbohydrate Research and Distinguished Professor of Food Science, and Thaisa Moro Cantu-Jungles, his postdoctoral research associate, recently discovered a way to select prebiotic fibers that have the potential to provide improvement of gut health where everyone would benefit. Their study, conducted in vitro, showed an increase in butyrate-producing bacteria with a selected fiber using this new approach. Butyrate is a short-chain fatty acid that supports many of the body’s essential functions from regulating the immune system to digestive health. In donors’ gut flora where these bacter...
Read more